<DOC>
	<DOC>NCT00454545</DOC>
	<brief_summary>Open pilot study to collect information regarding the effect of atorvastatin on patients with active Crohns disease.</brief_summary>
	<brief_title>Atorvastatin in Moderate Active Crohns Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Clinical diagnosis of Crohns disease Creactive protein level &gt; 2 mg/L in absence of an infection Fecal calprotectin &gt; 250 mg/kg or CDAI &gt; 150 CDAI &gt; 450 Prednisolone dosage above 15 mg/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>